Charles Jennisch
Psychiatry · Urbandale, IANPI 1225133606
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $716,239 of the $948,571 with a category attached, or 75.5%. 21 manufacturers reported payments, led by Otsuka America Pharmaceutical, Inc. at 49.8% of the total. Among psychiatry clinicians in IA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 1,273 payments — averaging $745.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$472K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$150K
- Axsome Therapeutics, Inc.$134K
- Neurocrine Biosciences, Inc.$68K
- E.r. Squibb & Sons, L.L.C.$47K
- Takeda Pharmaceuticals U.S.A., Inc.$40K
- plus $37K from 15 others
What the payments were for
- Consulting fees$151,61116%
- Speaking & faculty fees$716,23976%
- Travel & lodging$62,8917%
- Food & beverage$17,6842%
- Education$1460%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 559 | $472,185 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 181 | $149,884 |
| Axsome Therapeutics, Inc. | 165 | $134,134 |
| Neurocrine Biosciences, Inc. | 111 | $67,889 |
| E.r. Squibb & Sons, L.L.C. | 61 | $47,408 |
| Takeda Pharmaceuticals U.S.A., Inc. | 60 | $40,066 |
| Johnson & Johnson | 42 | $21,797 |
| AbbVie(2 entities) | 41 | $8,281 |
| Sunovion Pharmaceuticals Inc. | 24 | $3,553 |
| Alkermes, Inc. | 3 | $1,353 |
| Idorsia Pharmaceuticals US Inc | 1 | $1,190 |
| Jazz Pharmaceuticals Inc. | 4 | $147 |
| Teva Pharmaceuticals USA, Inc. | 3 | $135 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $125 |
| Ironshore Pharmaceuticals Inc. | 3 | $124 |
| Vanda Pharmaceuticals Inc. | 4 | $103 |
| Bausch Health US, LLC | 2 | $63 |
| Shire North American Group Inc | 3 | $50 |
| Lundbeck LLC | 2 | $39 |
| Corium, LLC | 1 | $22 |
| Supernus Pharmaceuticals, Inc. | 1 | $22 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$948,571 in reported general payments places this provider in the 95th percentile of 245 psychiatry providers in Iowa.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ZyprexaOlanzapine | 21 | $22,337 |
| CaplytaLumateperone Tosylate | 13 | $21,663 |
| AuvelityDextromethorphan Hbr/Bupropion | 15 | $18,183 |
| TrintellixVortioxetine Hydrobromide | 19 | $17,792 |
| Bupropion XlBupropion Hcl | 81 | $3,210 |
| Vilazodone Hcl | 21 | $2,977 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 100 | $2,436 |
| Clozapine | 27 | $2,001 |
| Duloxetine Hcl | 54 | $1,618 |
| Quetiapine Fumarate | 89 | $1,602 |
| Buspirone Hcl | 57 | $1,450 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 20 | $1,268 |
| Clonazepam | 97 | $1,189 |
| Mirtazapine | 40 | $686 |
| Methylphenidate Hcl | 15 | $668 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $149,884 | $21,66313 claims |
| Axsome Therapeutics, Inc.Auvelity | $134,134 | $18,18315 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $40,066 | $17,79219 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 245 psychiatry providers in Iowa.
Other psychiatry in Urbandale
- Scott EastinUrbandale$1K
- Ara RobinsonUrbandale$817
- Manmohan SinghDes Moines$408K
- Jimmy MascaroOttumwa$361K
- Alan WhittersCedar Rapids$170K
- Donald BlackIowa City$19K
- William CoryellIowa City$18K
- Randall KavalierWest Des Moines$15K
- Dwight SchroederCedar Rapids$13K
- Rodney DeanSioux City$11K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.